We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Healthcare keiretsu

19 March 2013 By Robert Cyran

The American and European drug chains haven’t finished merging their cross-border operations. They’re adding distributor Amerisource to the mix by taking a minority stake. Cost savings and negotiating heft may follow, but the combined firms’ management could be stretched thin.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)